Global and United States Stromal Vascular Fraction Market Report & Forecast 2022-2028

Stromal vascular fraction skin treatment is a type of stem cell therapy based on isolation of adipose tissue during liposuction or lipo-aspiration procedures of patient’s own body.
Market Analysis and Insights: Global and United States Stromal Vascular Fraction Market
This report focuses on global and United States Stromal Vascular Fraction market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global Stromal Vascular Fraction market size is estimated to be worth US$ 83 million in 2022 and is forecast to a readjusted size of US$ 102.5 million by 2028 with a CAGR of 3.7% during the review period. Fully considering the economic change by this health crisis, by Type, SVF Isolation Products accounting for % of the Stromal Vascular Fraction global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Application, Hospitals was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
With increasing age, regenerative and repair properties of skin are less effective due to decrease in stem cell count, and therefore, stromal vascular fraction treatment contains stem cell provides a boost in repair and maintenance mechanism of the skin leaving smooth, healthy, radiant skin.
Global Stromal Vascular Fraction Scope and Market Size
Stromal Vascular Fraction market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Stromal Vascular Fraction market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Stromal Vascular Fraction market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type
SVF Isolation Products
Enzymatic Isolation
Non-enzymatic Isolation
Automated POC Devices
SVF Aspirate Purification Products
SVF Transfer Products
Segment by Application
Hospitals
Specialty Clinics
Stem Cell Banks/Laboratories
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Cytori Therapeutics
GE Healthcare
Ingeneron
Medikan International
Tissue Genesis
Genesis Biosystems
Human Med
IntelliCell BioSciences
LifeCell